Close Menu

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Signatures today said that it plans to offer up to A$15 million (US$13.1 million) of its shares in an initial public offering.

The firm said in a prospectus that it seeks to raise between A$12 million (US$10.5 million) and A$15 million through an offering of up to 37.5 million shares of its stock at A$.40 per share. Proceeds will be used primarily to fund expansion into the European and US markets and the development of additional products, according to the company's prospectus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.